Meridian Management CO Amgen Inc Transaction History

Meridian Management CO

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 May 08, 2018	SELL	$169.43 - $198.0 $2.43 Million - $2.84 Million	-14,361 Closed	0 $0
Q4 2017 Feb 05, 2018	SELL	$168.79 - $188.59 $21,942 - $24,516	-130 Reduced 0.9%	14,361 $2.5 Million
Q3 2017 Nov 06, 2017	BUY	$167.29 - $191.0 $2.42 Million - $2.77 Million	14,491	14,491 $0

3,085

417M

7.19M

6.11M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $172B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Meridian Management CO, based on Form 13F filings with the SEC.

Stay updated on Meridian Management CO with notifications on news.